Moderna (MRNA) Reports Wide Q3 Loss on $3.1B Charge, as Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Moderna (MRNA) downside has played out, HSBC raises rating
November 3, 2023 9:49 AM EDTModerna (NASDAQ: MRNA) was raised to Hold from Reduce at HSBC on Friday, with the firm raising the price target for the stock to $89 from $69 per share.
The investment bank's analyst, Yifeng Liu, said that the downside they saw for the company has... More
